Simple Summary Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare form
of liver cancer with features of both hepatocellular and biliary tract cancer. Locoregional …

Cholangiocarcinoma (CCA) is a rare cancer originating from the biliary epithelium and
accounts for about 3% of all gastrointestinal malignancies. Unfortunately, the majority of …

Abstract Background/Aims The aim of this study was to examine whether the efficacy of
radiofrequency ablation (RFA) and surgical resection (SR) are comparable for …

Tumor-infiltrating immune cells and their crosstalk with cancer cells in the tumor
microenvironment (TME) play a crucial role in shaping tumor progression and response to …

Minimally invasive adrenalectomy has become the main treatment modality for most adrenal
lesions. Both laparoscopic transabdominal and retroperitoneoscopic approaches are safe …

Background Hepatic thermal ablation has been found to be effective and equivalent to
resection in certain liver histologies. Of the 16,000 annual liver ablations performed in the …

Cholangiocarcinoma (CCA) is a rare form of cancer, accounting for approximately 3% of all
gastrointestinal cancers and 15% of primary liver malignancies. Most patients will require a …

Patients affected by pancreatic ductal adenocarcinoma (PDAC) have very poor prognosis,
with the mortality rate very similar to the incidence rate at the follow-up of 5 years (1, 2) …

Background/Aim: Ablating a spherical area during hepatocellular carcinoma ablation
therapy is a very important issue. We aimed to determine the ablation area of bovine liver …

Cholangiocarcinoma (CCA) is a rare form of cancer, accounting for approximately 3% of all
gastrointestinal cancers and 15% of primary liver malignancies. Most patients will require a …